INVESTIGADORES
VAZQUEZ Fernando Javier
artículos
Título:
Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in Argentina: A multicentric cross-sectional study
Autor/es:
VAZQUEZ, FERNANDO; WATMAN, RICARDO; TABARES, ALDO; GUMPEL, CARINA; BALDESSARI, ENRIQUE; VILASECA, ALICIA B.; CAPPARELLI, FEDERICO J.; LIFSCHITZ, ESTEBAN
Revista:
Thrombosis Journal
Editorial:
BioMed Central Ltd.
Referencias:
Año: 2014 vol. 12
Resumen:
Background: Venous thromboembolic disease (VTE) is associated with high morbi-mortality. Adherence rate to the recommendations of antithrombotic prophylaxis guidelines (ATPG) is suboptimal. The aim of this study was to describe the adequacy of antithrombotic prophylaxis (ATP) in hospitalized patients as the initial stage of a program designed to improve physician adherence to -ATP recommendations in Argentina.Methods: This study was a multicenter, cross-sectional study that included 28 Institutions throughout 5 provinces in Argentina.Results: 1315 patients were included, 729 (55.4%) were hospitalized for medical (clinical) reasons, and 586 (44.6%) for surgical reasons. Adequate ATP was provided to 66.9% of the patients and was more frequent in surgical (71%) compared to clinical (63.6%) subjects (p < 0.001). Inadequate ATP resulted from underuse in 76.6% of the patients. Among clinical, 203 (16%) had increased bleeding risk and mechanical ATP was used infrequently.Conclusions: The adequacy of ATP was better in low VTE risk clinical and surgical patients and high VTE risk in orthopedic patients. There was worse adequacy in high risk patients (with active neoplasm) and in those with pharmacological ATP contraindications, in which the use of mechanical methods was scarce. The adequacy of ATP was greater at institutions with < 150 beds compared with larger institutions. This is the first multicentric study reporting ATP in Argentina. Understanding local characteristics of medical performance within our territory is the first step in order to develop measures for improving ATP in our environment. © 2014 Vazquez et al.; licensee BioMed Central Ltd.